TypeZero Technologies received the first investment from the UVA LVG Seed Fund in 2016 CHARLOTTESVILLE, Va. (September 11, 2018) – The University of Virginia Licensing & Ventures Group (UVA LVG) Seed Fund has exited from TypeZero Technologies, In...
According to the American Epilepsy Society, one in 26 Americans will develop epilepsy in their lifetime. The fourth most common neurological disease, epilepsy predisposes a person to recurrent unprovoked seizures and is a major public health concern ...
In medicine, there can be a frustrating paradox where the most innovative forms of treatment are available for patients, but scientific advancements are not simultaneously advancing the tools used to deliver them. Tim Showalter, MD, a radiation oncol...
This summer, the UVA LVG Seed Fund hosted two rising second-year Darden MBA interns, Grant Lischick and Russell Wilson. After three months of hard work, here's what they have to share about their experiences. "Venture Capital is an apprenticeship bu...
Amy Mathers, MD, Associate Professor of Medicine and Pathology, Division of Infectious Disease and International Health at UVA has been studying molecular epidemiology for more than ten years. Her expertise in tracking bacterial DNA sequences has adv...
Each year, an estimated 300,000 cases of Lyme disease are reported in the United States. Lyme disease can cause joint pain, fatigue, and muscle stiffness, and can lead to devastating neurological problems. Nonspecific symptoms make diagnosing Lyme di...
In September 2016, Samsung issued a massive recall of the Galaxy Note 7 phone after a manufacturing defect caused the phones’ batteries to generate excessive heat and catch fire. The exploding phone PR nightmare gave everyone who carries a cell phone...
In 2008, UVA Professor of Infectious Disease, Paul Hoffman, Ph.D. along with one of UVA’s most prolific inventors and two-time winner of the Innovator of the Year Award (1997, 2010), Professor of Chemistry and Pharmacology Tim Macdonald, Ph.D. submit...
UVA Biology Professor, Michael Timko, Ph.D. has been studying functional genomics of plants at UVA for over 30 years. He has conducted sponsored research ranging from the examination of photosynthetic efficiency of pine trees in the southern United S...
The UVA LVG Seed Fund recently concluded its second year of Due Diligence in Seed Funds, an elective course in the entrepreneurship, innovation, and strategy discipline of Darden's MBA curriculum. The course offered eleven second-year Darden students...